(Sharecast News) - Drugmaker GSK reported two sets of encouraging cancer‑drug results on Monday, with fresh data for its experimental ovarian‑cancer therapy Mo‑Rez and new interim findings for Jemperli in rectal cancer, both due to be presented at the ESMO Congress.
In ovarian cancer, updated phase I results for Mo‑Rez showed...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE